Paracel Explorer

Dernière publication·Octobre 2026

Octreotid Labatec

Octreotidum — sol inj 0.05 mg/ml

Labatec Pharma SA

Swissmedic63241

Dossier20254

Statut

Générique

OriginauxSandostatine, Sandostatine LAR

Remboursement

QP 10%

Modifications (6)